Breast cancer pill from AstraZeneca misses mark in pivotal trial The company is continuing to test the drug, called Etcamah, in early-stage disease By Andrew JosephSept. 12, 2026 Europe Correspondent

https://www.statnews.com/2026/09/12/astrazeneca-breast-cancer-camizestrant-etcamah-serena-4-trail-failure/?utm_campaign=the_readout&utm_medium=email&_hsenc=p2ANqtz--3eaRoWoyFbdAnrBWLSE_RVAU5V7w0lUZaMyKFeMfmwuDszRpWvC8iCOWCHJi5ED1bwCPIRc3jUEZJEzYk18Qgp6LM1A&_hsmi=438904019&utm_content=438904019&utm_source=hs_email